HK1164869A1 - Azabicyclo compound and salt thereof - Google Patents

Azabicyclo compound and salt thereof

Info

Publication number
HK1164869A1
HK1164869A1 HK12105624.9A HK12105624A HK1164869A1 HK 1164869 A1 HK1164869 A1 HK 1164869A1 HK 12105624 A HK12105624 A HK 12105624A HK 1164869 A1 HK1164869 A1 HK 1164869A1
Authority
HK
Hong Kong
Prior art keywords
salt
azabicyclo compound
azabicyclo
compound
Prior art date
Application number
HK12105624.9A
Other languages
Chinese (zh)
Inventor
Makoto Kitade
Shuichi Ohkubo
Chihoko Yoshimura
Satoshi Yamashita
Hiromi Oshiumi
Takao Uno
Yuichi Kawai
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of HK1164869A1 publication Critical patent/HK1164869A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK12105624.9A 2009-07-10 2012-06-08 Azabicyclo compound and salt thereof HK1164869A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009164196 2009-07-10
PCT/JP2010/004466 WO2011004610A1 (en) 2009-07-10 2010-07-09 Azabicyclo compound and salt thereof

Publications (1)

Publication Number Publication Date
HK1164869A1 true HK1164869A1 (en) 2012-09-28

Family

ID=43429037

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12105624.9A HK1164869A1 (en) 2009-07-10 2012-06-08 Azabicyclo compound and salt thereof

Country Status (19)

Country Link
US (2) US8779142B2 (en)
EP (1) EP2452940B1 (en)
JP (1) JP5227456B2 (en)
KR (1) KR101609412B1 (en)
CN (2) CN102471335B (en)
AU (1) AU2010269674B2 (en)
BR (1) BRPI1013999B1 (en)
CA (1) CA2767556C (en)
DK (1) DK2452940T3 (en)
ES (1) ES2527222T3 (en)
HK (1) HK1164869A1 (en)
MX (1) MX2012000487A (en)
MY (1) MY152972A (en)
PL (1) PL2452940T3 (en)
PT (1) PT2452940E (en)
RU (1) RU2565078C2 (en)
SG (1) SG177306A1 (en)
TW (1) TWI460177B (en)
WO (1) WO2011004610A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103140490A (en) 2010-07-15 2013-06-05 百时美施贵宝公司 Azaindazole compounds
EP2638041B1 (en) * 2010-11-12 2015-07-22 Bristol-Myers Squibb Company Substituted azaindazole compounds
RU2013136895A (en) 2011-01-07 2015-02-20 Тайхо Фармасьютикал Ко., Лтд. NEW BICYCLE COMPOUND OR ITS SALT
AU2012204650A1 (en) * 2011-01-07 2013-08-01 Taiho Pharmaceutical Co., Ltd. Novel indole or indazole derivative or salt thereof
EP2760870B1 (en) 2011-09-27 2016-05-04 Bristol-Myers Squibb Company Substituted bicyclic heteroaryl compounds
EP2867232B1 (en) 2012-06-27 2018-08-08 F.Hoffmann-La Roche Ag 5-azaindazole compounds and methods of use
SG11201600759XA (en) * 2013-08-22 2016-03-30 Taiho Pharmaceutical Co Ltd Novel quinoline-substituted compound
AU2014325016C1 (en) 2013-09-30 2021-10-07 Taiho Pharmaceutical Co., Ltd. Combination therapy using azabicyclo compound for cancer
US10100095B2 (en) 2013-10-02 2018-10-16 Taiho Pharmaceutical Co., Ltd. Resistant mutant 90 kDa heat shock protein
KR102412146B1 (en) * 2015-02-11 2022-06-22 주식회사 아이엔테라퓨틱스 Sodium channel blockers
AU2016260279B2 (en) 2015-05-12 2019-03-14 Taiho Pharmaceutical Co., Ltd. Crystals of azabicyclic compound
JOP20190073A1 (en) 2016-10-31 2019-04-07 Taiho Pharmaceutical Co Ltd Selective inhibitor of exon 20 insertion mutant egfr
CN108976150B (en) * 2017-06-05 2022-11-18 重庆博腾制药科技股份有限公司 Preparation method of 3-ethyl-4-fluorobenzonitrile
AU2018291366B2 (en) * 2017-06-30 2022-10-27 Taiho Pharmaceutical Co., Ltd. Chemotherapy for cancer using azabicyclo compound
CN111465397B (en) 2017-09-01 2023-10-13 大鹏药品工业株式会社 Selective inhibitors of EGFR mutant at exon 18 and/or exon 21
KR102403289B1 (en) * 2017-09-15 2022-05-30 다이호야쿠힌고교 가부시키가이샤 Prevention and/or treatment of diseases involving the expression of IDO
AU2018423606A1 (en) 2018-05-14 2021-01-07 Taiho Pharmaceutical Co., Ltd. Method of treating malignant tumor by azabicyclic compound
KR20230088763A (en) * 2020-10-14 2023-06-20 라녹 테라퓨틱스 (항저우) 컴퍼니, 리미티드 Methods and compositions for targeted protein degradation
CN114685492A (en) * 2020-12-31 2022-07-01 杭州领业医药科技有限公司 TAS-116 crystal form, preparation method, pharmaceutical composition and application thereof
CN116981669A (en) * 2021-02-05 2023-10-31 上海齐鲁制药研究中心有限公司 Pyrimidine or pyrido heterocyclic adenosine receptor inhibitor, preparation method and application thereof
CN117003754A (en) * 2022-04-28 2023-11-07 腾讯科技(深圳)有限公司 Pyrrolo [2,3-d ] pyrimidine or pyrazolo [3,4-d ] pyrimidine derivatives and uses thereof
CN115960100B (en) * 2022-12-28 2023-08-18 北京康立生医药技术开发有限公司 Synthesis method of Pi Mite xib drug for treating gastrointestinal stromal tumor

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451566A (en) * 1993-11-17 1995-09-19 Zeneca Limited Herbicidal pyrrolopyridine compounds
BRPI0414533A (en) * 2003-09-18 2006-11-07 Conforma Therapeutics Corp compound, pharmaceutical composition, and methods for inhibiting an hsp90 and treating an individual having an hsp90 mediated disorder
WO2005058892A1 (en) * 2003-12-19 2005-06-30 Glaxo Group Limited Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
GB0425035D0 (en) * 2004-11-12 2004-12-15 Novartis Ag Organic compounds
ATE469151T1 (en) * 2005-05-16 2010-06-15 Irm Llc PYRROLOPYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS
AU2006279794B2 (en) * 2005-08-12 2011-04-07 Synta Pharmaceuticals Corp. Pyrazole compounds that modulate HSP90 activity
AU2006292429A1 (en) 2005-09-16 2007-03-29 Serenex, Inc. Carbazole derivatives
US20080119457A1 (en) 2006-08-24 2008-05-22 Serenex, Inc. Benzene, Pyridine, and Pyridazine Derivatives
GB0617161D0 (en) * 2006-08-31 2006-10-11 Vernalis R&D Ltd Enzyme inhibitors
WO2008115719A1 (en) 2007-03-20 2008-09-25 Curis, Inc. Fused amino pyridine as hsp90 inhibitors
CA2682665C (en) * 2007-03-27 2015-07-21 Synta Pharmaceuticals Corp. Triazinone and diazinone derivatives useful as hsp90 inhibitors
WO2010106290A1 (en) * 2009-03-19 2010-09-23 Sanofi-Aventis Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof
AU2012204650A1 (en) 2011-01-07 2013-08-01 Taiho Pharmaceutical Co., Ltd. Novel indole or indazole derivative or salt thereof
RU2013136895A (en) 2011-01-07 2015-02-20 Тайхо Фармасьютикал Ко., Лтд. NEW BICYCLE COMPOUND OR ITS SALT

Also Published As

Publication number Publication date
AU2010269674A2 (en) 2012-02-16
KR101609412B1 (en) 2016-04-05
BRPI1013999B1 (en) 2020-06-02
PL2452940T3 (en) 2015-05-29
EP2452940A4 (en) 2012-12-12
DK2452940T3 (en) 2015-01-12
JP5227456B2 (en) 2013-07-03
CN102471335A (en) 2012-05-23
EP2452940A1 (en) 2012-05-16
CA2767556A1 (en) 2011-01-13
BRPI1013999A2 (en) 2016-04-05
AU2010269674B2 (en) 2014-01-16
TWI460177B (en) 2014-11-11
KR20120035181A (en) 2012-04-13
CN104710420A (en) 2015-06-17
US9273045B2 (en) 2016-03-01
AU2010269674A1 (en) 2012-01-19
US8779142B2 (en) 2014-07-15
RU2012104700A (en) 2013-08-20
CN102471335B (en) 2015-09-30
US20120108589A1 (en) 2012-05-03
PT2452940E (en) 2015-02-27
SG177306A1 (en) 2012-02-28
MX2012000487A (en) 2012-01-27
WO2011004610A1 (en) 2011-01-13
TW201105670A (en) 2011-02-16
CN104710420B (en) 2016-07-27
RU2565078C2 (en) 2015-10-20
EP2452940B1 (en) 2014-12-17
JPWO2011004610A1 (en) 2012-12-20
ES2527222T3 (en) 2015-01-21
MY152972A (en) 2014-12-15
CA2767556C (en) 2017-11-28
US20140303162A1 (en) 2014-10-09

Similar Documents

Publication Publication Date Title
HUS2100007I1 (en) Filgotinib or salt
HK1164869A1 (en) Azabicyclo compound and salt thereof
ZA201303499B (en) Specific diarylhydantoin and diarylthiohydantion compounds
IL220939A0 (en) Compounds and methods
HUE059796T2 (en) Psma-targeting compounds and uses thereof
EP2523664A4 (en) Compounds and methods
EP2423182A4 (en) Diacylethylenediamine compound
EP2416657A4 (en) Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods for use thereof
GB0903759D0 (en) Compound
IL220812A0 (en) Compounds and methods
EP2523560A4 (en) Compounds and methods
PL2278285T3 (en) Connectable load-bearer
GB0914767D0 (en) Compound
EP2505585A4 (en) Bis-benzoxazinone compound
GB0909213D0 (en) Compound
GB0902173D0 (en) Compounds and their use
GB0922510D0 (en) Compound and use
GB0914883D0 (en) Compound
EP2470022A4 (en) Compounds and methods
EP2487178A4 (en) Pyrazolothiazole compound
GB0903348D0 (en) Compounds and methods relating thereto
PT2274977E (en) Fishhook
EP2635298A4 (en) Antivenom
GB0905525D0 (en) Compounds and uses
EP2502926A4 (en) Compound